“With all thy getting, get understanding." As the Trump Administration and its DOGE team aggressively—and rightfully—ferret out ways to reduce wasteful and abusive government spending, they ...
Obesity in India: Regular physical activity is essential for maintaining a healthy weight During his monthly Mann Ki Baat radio broadcast, Prime Minister Narendra Modi urges the country to draw ...
Four Wisconsin companies are among Forbes' 100 best employers in the country for 2025. Every year, the business magazine and news site compiles its lists of America's Best Large Employers and ...
For the fourth straight year, Forbes is building the definitive list of the 50 most powerful social media content creators. Do you know someone making millions of dollars and attracting millions ...
Prime Minister Narendra Modi in his Mann Ki Baat broadcast highlighted the critical issue of obesity, citing WHO data that indicates 250 crore people globally were overweight in 2022. He ...
Lilly’s tirzepatide drugs, Zepbound for obesity and Mounjaro for diabetes ... Lilly’s president of cardiometabolic health, told Forbes in an interview at the J.P. Morgan healthcare conference ...
Some dogs, like Labrador retrievers, are prone to obesity. Scientists have investigated the genetics of British Labrador retrievers and found several obesity-linked genes that were then also ...
Tuesday, February 18, 2025 – Forbes today unveiled the annual Fintech 50, spotlighting the top private companies transforming finance through technology. Marking its tenth anniversary ...
Please provide your email address to receive an email when new articles are posted on . The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health ...
Jammu and Kashmir Chief Minister Omar Abdullah has expressed happiness in joining the campaign against obesity launched by Prime Minister Narendra Modi. PM Modi on Monday nominated Omar Abdullah ...
Lilly’s tirzepatide drugs, Zepbound for obesity and Mounjaro for diabetes ... Lilly’s president of cardiometabolic health, told Forbes in an interview at the J.P. Morgan healthcare conference in ...
In ongoing trials of Eli Lilly’s next-generation obesity drug, several participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of ...